StockData
Tenax Therapeutics, Inc. logo

Tenax Therapeutics, Inc. (TENX) stock

TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.42−0.06 (-4.05%)

Close on Nov 17, 2026Market cap $53.14MP/E –Yield –

Tenax Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

Tenax Therapeutics's gross margin for the twelve months ending Apr 30, 2015 was 0.0%. For fiscal 2015 it was 0.0%, against -65.5% the year before. The highest annual figure on record is 100.0% in fiscal 2011.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2015Apr 30, 20150.0%+65.5
FY2014Apr 30, 2014-65.5%−69.6
FY2013Apr 30, 20134.2%−9.4
FY2012Apr 30, 201213.5%−86.5
FY2011Apr 30, 2011100.0%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q4 FY2015CQ1 2015Apr 30, 20150.0%–

More Tenax Therapeutics figures

See a number that looks wrong?